At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 278 enrolled
Drug / intervention
Nicotine Replacement Therapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
In Brief
A Phase 4 clinical trial evaluating Nicotine Replacement Therapy and Smoking Cessation Counseling for Smoking Cessation. Completed, enrolled 278 participants across 2 sites.
Detailed Summary
The researchers are testing if counseling alone or counseling plus over-the-counter nicotine replacement therapies (NRT), like the patch,gum, or lozenge, helps African American non-daily smokers quit smoking.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 2014
Enrollment StartMay 2015
Primary CompletionNov 2017
Study CompletionMar 2018
TodayJul 2026
First PostedSep 19, 2014
Enrollment StartMay 1, 2015
Primary CompletionNov 1, 2017
Study CompletionMar 15, 2018
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 11.8 years ago
Interventions
Nicotine Replacement Therapydrug
Participant has choice of from over-the-counter nicotine patch, nicotine gum or lozenge.
Smoking Cessation Counselingbehavioral